Blueberries and Heart Health: The Cardiovascular Evidence You Need to Know

Cardiovascular disease remains the leading cause of death globally, and dietary interventions that can meaningfully reduce risk are among the most important tools in preventive medicine. Blueberries — or more precisely, the anthocyanins they contain — have accumulated a substantial and growing evidence base for cardiovascular protection that spans from large epidemiological cohort studies to mechanistic clinical trials measuring direct vascular biomarkers.

The cardiovascular evidence for blueberries is arguably even stronger than the cognitive evidence — with a particularly landmark finding from the Nurses Health Study that placed blueberry and strawberry anthocyanin intake among the most significant dietary predictors of heart attack risk in a population of over 93,000 women followed for 18 years.

The Harvard Nurses' Health Study Finding

A 2013 study published in Circulation (one of the world's most respected cardiology journals) analysed data from 93,600 women aged 25–42 enrolled in the Nurses' Health Study II, followed for 18 years. The study specifically examined flavonoid intake — and found that women with the highest intake of anthocyanins from blueberries and strawberries had a 32% lower risk of myocardial infarction (heart attack) compared to those consuming the lowest amounts, even after adjusting for all other cardiovascular risk factors including diet quality, exercise, BMI, and smoking.

The specific mechanism proposed was endothelial function: women consuming three or more servings of blueberries or strawberries per week showed the greatest cardiovascular benefit. Crucially, total fruit and vegetable intake was not the predictor — the association was specific to high-anthocyanin fruits, pointing directly to anthocyanins rather than general dietary quality as the active factor.

This is one of the strongest dietary-cardiovascular associations reported in a large prospective cohort — comparable in magnitude to the cardiovascular benefits attributed to Mediterranean diet adherence.

How Anthocyanins Protect the Heart: Mechanisms

1. Endothelial Function and Nitric Oxide

The endothelium — the single-cell layer lining all blood vessels — is the primary interface between blood and vascular tissue. Endothelial dysfunction (reduced nitric oxide production, increased oxidative stress, impaired vasodilation) is the earliest and most fundamental step in cardiovascular disease development, preceding atherosclerosis, hypertension, and coronary artery disease by decades. Blueberry anthocyanins improve endothelial function through three related mechanisms:

• Upregulation of eNOS (endothelial nitric oxide synthase) — increasing NO production
• Protection of NO from oxidative degradation by superoxide — increasing bioavailable NO
• Reduction of ADMA (asymmetric dimethylarginine) — an endogenous NOS inhibitor elevated in cardiovascular disease

A 2025 meta-analysis in International Journal of Food Sciences and Nutrition pooled 14 RCTs of berry consumption on endothelial function and found significant improvements in flow-mediated dilation (FMD) — the gold-standard measure of endothelial function — with the effects being significantly larger in participants with pre-existing endothelial dysfunction.

2. Blood Pressure Reduction

Multiple clinical trials have demonstrated significant blood pressure reductions with blueberry supplementation, consistent with the endothelial/NO mechanism. A meta-analysis of 11 RCTs found blueberry supplementation reduced systolic blood pressure by an average of 4.96 mmHg and diastolic by 3.27 mmHg compared to placebo. For context, a 5 mmHg reduction in systolic blood pressure is associated with approximately 10% lower risk of cardiovascular events in large population studies — making this a clinically meaningful effect size. The 6-month Whyte RCT specifically showed reduced systolic blood pressure in the blueberry extract group.

3. LDL Oxidation Prevention

Oxidised LDL cholesterol (oxLDL) — not total LDL — is the form of LDL that drives atherosclerosis. When LDL particles become oxidised by free radicals, they are taken up by macrophages in arterial walls to form foam cells — the building blocks of atherosclerotic plaques. Blueberry anthocyanins significantly reduce LDL oxidation through their potent free radical scavenging activity (particularly cyanidin) and through direct inhibition of copper-mediated LDL oxidation in vitro. Clinical trials have consistently shown reductions in oxLDL biomarkers (including malondialdehyde-modified LDL) with blueberry supplementation.

4. Platelet Aggregation Inhibition

Platelet aggregation — the clustering of platelets that initiates blood clots — is a critical mechanism in heart attack and stroke. Blueberry anthocyanins inhibit platelet aggregation through ADP and collagen-induced pathways, producing an antiplatelet effect that contributes to reduced thrombotic risk. This mechanism is part of the suite of vascular benefits that collectively explain the epidemiological association with lower heart attack rates.

5. Cholesterol and Triglyceride Modulation

A systematic review of 14 RCTs found consistent (though modest) improvements in lipid profiles with blueberry supplementation: reductions in LDL cholesterol (mean −0.21 mmol/L), triglycerides, and total cholesterol, with increases in HDL cholesterol. The effects are most pronounced in individuals with pre-existing dyslipidaemia and metabolic syndrome — consistent with the pattern seen across most blueberry cardiovascular trials (greater effects in those with elevated baseline risk).

The 2025 Endothelial Function Meta-Analysis

The most comprehensive recent synthesis of berry cardiovascular evidence — published in International Journal of Food Sciences and Nutrition in 2025 — pooled data from RCTs examining both long-term and post-prandial effects of berry consumption on endothelial function across adults with and without cardiovascular conditions. The analysis confirmed statistically significant improvements in endothelial function biomarkers, with effect sizes suggesting that sustained berry consumption could reduce cardiovascular event risk comparably to low-dose antihypertensive medication in high-risk populations.

Gut Microbiome: The Underappreciated Cardiovascular Pathway

Emerging evidence highlights the gut microbiome as a critical intermediary for blueberry cardiovascular benefits. Anthocyanins that reach the colon are metabolised by gut bacteria into phenolic acids (particularly protocatechuic acid and vanillic acid) and urolithins — compounds with independent cardiovascular activity. Blueberry consumption has been shown to increase populations of beneficial gut bacteria (including Akkermansia muciniphila) associated with improved metabolic and vascular health, while reducing pathogenic bacteria that produce inflammatory lipopolysaccharides (LPS) linked to endothelial dysfunction.

This gut microbiome pathway explains why individual responses to blueberry supplementation vary considerably — people with diverse, healthy gut microbiomes produce more cardiovascular-active metabolites from the same blueberry dose.

Practical Protocol for Cardiovascular Health

• Daily intake target: 150–200g fresh/frozen blueberries, or equivalent 20–25g freeze-dried powder, or 400–500mg standardised extract (≥25% anthocyanins) twice daily
• Duration: 8+ weeks for measurable biomarker improvements; long-term consistent consumption for epidemiological-level risk reduction
• Timing: Consistent daily intake produces greater benefits than infrequent large doses — the vascular improvements are cumulative
• Highest priority populations: Adults with hypertension, elevated oxLDL, metabolic syndrome, family history of cardiovascular disease, or pre-existing endothelial dysfunction — these groups show the largest clinical benefits in trials